Business Description
Sandu Pharmaceuticals Ltd
ISIN : INE751D01014
Compare
Compare
Traded in other countries / regions
524703.India IPO Date
1994-09-12Description
Sandu Pharmaceuticals Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and sales of Ayurvedic pharmaceutical products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.76 | |||||
| Interest Coverage | 25.72 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.55 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.5 | |||||
| 3-Year EBITDA Growth Rate | 3.9 | |||||
| 3-Year EPS without NRI Growth Rate | 16.6 | |||||
| 3-Year Book Growth Rate | -0.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.14 | |||||
| 9-Day RSI | 59.26 | |||||
| 14-Day RSI | 53.77 | |||||
| 6-1 Month Momentum % | -10.51 | |||||
| 12-1 Month Momentum % | 15.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.19 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 125.89 | |||||
| Days Sales Outstanding | 32.63 | |||||
| Days Payable | 77.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.2 | |||||
| Dividend Payout Ratio | 0.65 | |||||
| Forward Dividend Yield % | 1.2 | |||||
| 5-Year Yield-on-Cost % | 1.2 | |||||
| 3-Year Average Share Buyback Ratio | -10.9 | |||||
| Shareholder Yield % | 1.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.73 | |||||
| Operating Margin % | 2.45 | |||||
| Net Margin % | 1.7 | |||||
| FCF Margin % | -1.27 | |||||
| ROE % | 2.9 | |||||
| ROA % | 2.15 | |||||
| ROIC % | 2.6 | |||||
| ROC (Joel Greenblatt) % | 7.02 | |||||
| ROCE % | 4.45 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 53.88 | |||||
| PE Ratio without NRI | 53.88 | |||||
| Shiller PE Ratio | 52.44 | |||||
| PS Ratio | 0.92 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.5 | |||||
| Price-to-Operating-Cash-Flow | 267.09 | |||||
| EV-to-EBIT | 31.35 | |||||
| EV-to-EBITDA | 24.18 | |||||
| EV-to-Revenue | 0.84 | |||||
| EV-to-FCF | -66.31 | |||||
| Price-to-Projected-FCF | 0.98 | |||||
| Price-to-Median-PS-Value | 1.9 | |||||
| Price-to-Graham-Number | 1.69 | |||||
| Price-to-Net-Current-Asset-Value | 4.76 | |||||
| Earnings Yield (Greenblatt) % | 3.19 | |||||
| FCF Yield % | -1.4 | |||||
| Forward Rate of Return (Yacktman) % | 4.01 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers